Trial Profile
A Randomized, Multicenter, Double-blind, Placebo-controlled, Dose-range-finding, Parallel-group, Phase 2 Trial of Oral Linaclotide Acetate Administered to Patients With Chronic Constipation
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 14 Jan 2020
Price :
$35
*
At a glance
- Drugs Linaclotide (Primary)
- Indications Constipation
- Focus Therapeutic Use
- Sponsors Ironwood Pharmaceuticals
- 31 Dec 2009 Results published in Gastroenterology.
- 20 May 2008 Results have been presented at the Digestive Disease Week conference, reported by Ironwood Pharmaceuticals and Forest Laboratories in a media release.
- 14 May 2008 Status changed from in progress to completed, reported by ClinicalTrials.gov